Ann: ResAppDx-EU to be Deployed on Phenix Health Telehealth App, page-173

good point about fda rejection ..and without the current need for Telehealth apps RAP would be toast ..but with Ce and tga and the pressing need and growing trend for remote Telehealth products .. RAP will survive and make money ...problem tk is facing is in the sales pitch explaining fda rejection..they need to refill ..if anything to look like they can get it the second time around.. once the build up enough revenue who cares ..and fda May come along to the party with real world customers